Nussbaum Ran
CIK 0001609805
Director10% Owner
Filings
13
Latest Oct 17, 2025
Issuers covered
4
Showing
13 of 13
Page 1
Track record
5 of 5 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 5 | 0% | -16.2% | -19.1% | -4.3% | -19.1% |
| 90 days | 5 | 20% | -23.6% | -34.6% | +20.4% | -34.6% |
| 180 days | 5 | 100% | +27.8% | +23.1% | +46.9% | +23.1% |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Nussbaum Ran has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| KROS | Keros Therapeutics, Inc. | 6 | Oct 17, 2025 |
| URGN | Urogen Pharma Ltd. | 4 | Feb 28, 2023 |
| LBRX | Lb Pharmaceuticals Inc | 2 | Sep 16, 2025 |
| ELOX | Eloxx Pharmaceuticals, Inc. | 1 | Jun 17, 2022 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|